| Bioactivity | RIPK1-IN-24 is a receptor-interacting protein kinase 1 (RIPK1) inhibitor with an IC50 value of 1.3 μM. RIPK1-IN-24 can be used for research on inflammatory diseases[1]. |
| CAS | 1358585-26-8 |
| Formula | C26H21FN6O2 |
| Molar Mass | 468.48 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Yu Y, et al. Discovery of 5-(1-benzyl-1H-imidazol-4-yl)-1,2,4-oxadiazole derivatives as novel RIPK1 inhibitors via structure-based virtual screening. Drug Dev Res. 2024 Aug;85(5):e22235. |
RIPK1-IN-24
CAS: 1358585-26-8 F: C26H21FN6O2 W: 468.48
RIPK1-IN-24 is a receptor-interacting protein kinase 1 (RIPK1) inhibitor with an IC50 value of 1.3 μM. RIPK1-IN-24 can
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.